These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
    Author: Robak T.
    Journal: Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543.
    Abstract:
    The antigenic phenotype of erythroid progenitor cells (BFU-E and CFU-E) in bone marrow and peripheral blood from normal individuals and patients with chronic granulocytic leukaemia (CGL) was studied using 14 myeloid monoclonal antibodies (Mc Abs) in a complement dependent cytotoxicity assay followed by culture in methylcellulose. Mc Abs which reacted with normal CFU-GEMM and CFU-GM antigens usually reacted strongly with normal and CGL-BFU-E. In contrast, the majority of myeloid Mc Abs used in the study reacted poorly or did not recognize the antigens on normal and CGL CFU-E. HLA-DR antigens recognized by L243 Mc Ab were expressed on the majority of BFU-E from blood and bone marrow of normal individuals and CGL patients. On the other hand, those antigens were not expressed on normal and leukaemic CFU-E. Two Mc Abs, R1.B19 and WGHS29.1, which recognised the antigens on "late" CFU-GM and not on "early" CFU-GM reacted with a higher proportion of BFU-E from the marrow and blood of CGL patients than of normal subjects. These results indicate that BFU-E in CGL are more differentiated than their normal counterparts. The Mc Ab 54/39, frequently expressed on platelets, recognized a higher percentage of BFU-E and CFU-E from CGL patients than from normal individuals. This may suggest that in CGL there exists a tendency for the expression of megakaryocytic markers on erythroid progenitor cells.
    [Abstract] [Full Text] [Related] [New Search]